Work

Neuropilin/vascular endothelial growth factor signaling in endothelial cells

Year: 2007
Type: dissertation
Abstract: Neuropilins were originally discovered in the nervous system. The subsequent characterization of transgenic mice revealed that Neuropilins also play important roles during vascular development (Kitsukawa et al., 1995). Later neuropilin was identified to be a receptor for class 3 semaphorins on neurons (He and Tessier-Lavigne, 1997;Kolodkin et al., 1997) and for VEGF165 on tumor cells and EC (Soker et al., 1998). NP-1 deficient mice die between E12.5 and 13.5 (Kawasaki et al., 1999) suggesting that NP-1 is not necessary for vasculogenesis, but for remodelling events after vasculogenesis has taken place. To date, it is hypothesized that VEGF165 forms an extracellular “bridge” between NP-1 and VEGFR-2, leading to complex formation and enhancement of VEGF-induced signaling through VEGFR-2. However, the molecular mechanisms behind neuropilin functions are not completely understood. In this study it was shown that siRNA mediated silencing of NP-1 or NP-2 leads to a decrease in both VEGF165- and VEGF121-induced in vitro EC sprouting, suggesting a role for NP-1 in VEGF121-induced signaling. This was supported by several studies showing that VEGF121 can also bind NP-1. However, VEGF121 does not induce complex formation between NP-1 and VEGFR-2. Therefore, the hypothesis that VEGF165-induced signaling is enhanced solely by the formation of a “bridge” is not correct. Neuropilins have a short cytoplasmic domain of 40 amino acids, which does not have enzymatic activities or known phosphorylation sites. To date, no studies have been performed to investigate the function of the cytoplasmic domain of NP-1 and its role in VEGFR-2 signaling. This study demonstrates that contrary to hitherto beliefs, the activation of VEGFR-2 is necessary for complex formation between NP-1 and VEGFR-2. Furthermore, the interaction is dependent on the cytoplasmic domain of NP-1, and more specifically, on the last three amino acids. These amino acids encode a PDZ-binding domain. The only protein known to bind the PDZ-binding domain of NP-1 is Synectin. Therefore, the complex formation between VEGFR-2 and NP-1 was studied in Synectin deficient mice and showed that NP-1 and VEGFR-2 form significantly less complexes in mice lacking Synectin. Taken together, these results show that, not only does VEGF165 form a bridge between VEGFR-2 and NP-1, but that the PDZ-binding domain is required for the association between NP-1 and VEGFR-2. VEGF has a high capacity of inducing vascular permeability, but it is not known which receptor specifically induces permeability effects induced by VEGF. In this study, it was shown that NP-1 became translocated to cell-cell-contacts upon stimulation with VEGF165. The translocation could not be inhibited by a Src kinase inhibitor or the VEGFR-phosphorylation inhibitor PTK787/ZK222584, suggesting that the translocation is independent of Src kinase and VEGFR-activity. Furthermore, a cytoplasmically truncated mutant of NP-1 did not translocate to cell-cell contacts, indicating that the cytoplasmic domain of NP-1 plays a role in this process. In addition, an antibody directed against NP-1 induced translocation of NP-1 to cell-cell contacts without the addition of VEGF165 and induced in vivo permeability in a dose dependent manner. Collectively, the data show a function of NP-1 in permeability, independent of VEGFR-2 activation.
Language: English
Open Access status: green
OpenAlex ID: W7011820732
Cites: 320
Cited by:
Related to: 10